Stockreport

CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug [Yahoo! Finance]

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF VIENNA, Va., February 06, 2024 BUSINESS WIRE )--CEL-SCI Corporation (NYSE American: CVM) today reported that its Multikine ® (Leukocyte Interleukin, Injection)* cGMP st [Read more]